A new antibiotic called teixobactin was discovered in January 2015 using a new technology called iCHIP. iCHIP allows single bacteria species to be isolated from soil samples and grown individually in lab conditions. This overcomes the challenge that only 1% of soil microbes can be cultured traditionally. Using iCHIP, researchers discovered teixobactin produced by the bacteria Eleftheria terrae. Teixobactin is effective against gram-positive bacteria and works by inhibiting cell wall synthesis. While further clinical trials are still needed, teixobactin has shown promise in mice. The development of iCHIP is as significant an achievement as the discovery of teixobactin, as it enables many more new antibiotics